Price
$7.37
Increased by +2.79%
Dollar volume (20D)
4.92 M
ADR%
5.43
Earnings report date
Aug 7, 2024
Shares float
70.63 M
Shares short
3.73 M [5.28%]
Shares outstanding
78.36 M
Market cap
561.82 M
Beta
2.15
Price/earnings
N/A
20D range
7.02 8.36
50D range
7.02 10.68
200D range
6.33 15.36

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians.

It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions.

In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions.

It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs.

The company was incorporated in 2007 and is headquartered in Seattle, Washington.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Apr 25, 24 -0.10
Increased by +76.19%
-0.07
Decreased by -42.86%
Jan 8, 24 -0.28
Increased by +50.00%
-0.44
Increased by +36.36%
Oct 4, 23 -0.43
Increased by +34.85%
-0.54
Increased by +20.37%
Jun 29, 23 -0.52
Increased by +16.13%
-0.62
Increased by +16.13%
Apr 27, 23 -0.42
Increased by +17.65%
-0.42
Jan 9, 23 -0.56
Decreased by -280.65%
-0.62
Increased by +9.68%
Oct 6, 22 -0.66
Increased by +31.96%
-0.72
Increased by +8.33%
Jun 30, 22 -0.62
Increased by +6.06%
-0.67
Increased by +7.46%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Feb 29, 24 124.83 M
Increased by +26.06%
-7.51 M
Increased by +75.33%
Decreased by -6.01%
Increased by +80.43%
Nov 30, 23 99.37 M
Increased by +9.26%
-21.06 M
Increased by +47.17%
Decreased by -21.20%
Increased by +51.65%
Aug 31, 23 96.86 M
Increased by +10.52%
-32.83 M
Increased by +29.44%
Decreased by -33.89%
Increased by +36.16%
May 31, 23 93.23 M
Increased by +9.00%
-38.41 M
Increased by +88.80%
Decreased by -41.20%
Increased by +89.72%
Feb 28, 23 99.03 M
Increased by +5.62%
-30.43 M
Increased by +11.93%
Decreased by -30.73%
Increased by +16.62%
Nov 30, 22 90.95 M
Increased by +8.98%
-39.87 M
Decreased by -277.19%
Decreased by -43.84%
Decreased by -262.58%
Aug 31, 22 87.64 M
Increased by +19.59%
-46.52 M
Increased by +25.40%
Decreased by -53.08%
Increased by +37.62%
May 31, 22 85.53 M
Increased by +43.68%
-342.82 M
Decreased by -603.85%
Decreased by -400.83%
Decreased by -389.87%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY